Board to approve September 2026 quarter and half-year audited results

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionResults View source PDF Explain this filing

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+11.1%Reaction day

₹403.50

prior close

₹405.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+11.1% vs market

Pharmaceuticals peers, median of 170sector+0.6%+10.6% vs sector

On the reaction day the stock moved 11.1 pts more than Nifty Microcap 250 and 10.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.5

10m

+3.5

15m

+7.0

30m

+9.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+11.1+0.1+11.1+0.6+10.6

Next day

+11.5+0.7+10.8+1.1+10.4

+8.8-1.8+10.6-0.3+9.0

+12.4-0.4+12.7+0.0+12.4

+15.6-0.1+15.7+0.4+15.2

+12.6+2.1+10.6+1.5+11.2

+10.5pendingpending+2.1+8.4

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on November 3, 2026, to approve audited financial results for the quarter and half year ended September 30, 2026. Trading will remain closed until 48 hours after the results are declared. No financial figures or audit findings were disclosed.

Likely market impact

The stock may react when the results are published, but this notice contains no earnings figures or guidance.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹826.2 Cr	₹652.8 Cr	+26.6%
Operating profit	₹106.7 Cr	₹60.32 Cr	+76.9%
Profit after tax	₹82.77 Cr	₹45.16 Cr	+83.3%
EBITDA margin	16.4%	12.9%	+3.5 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.